Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2810)
All Articles published online
|
Publishing Process of This Article
|
Aug 6, 2023 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang LM, Zhao P, Sun XQ, Yan F, Guo Q. Pathological complete response to neoadjuvant alectinib in unresectable anaplastic lymphoma kinase positive non-small cell lung cancer: A case report. World J Clin Cases 2023; 11(22): 5322-5328 [PMID: 37621597 DOI: 10.12998/wjcc.v11.i22.5322] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i22/5322.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Diego Luigi Cortinovis, Alessandro Leonetti, Alessandro Morabito, Luca Sala, Marcello Tiseo. Alectinib in Early-Stage Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Current Evidence and Future Challenges. Cancers 2024; 16(14): 2610 doi: 10.3390/cancers16142610
|